NCT03380689 2021-03-08
SIRB2
Fujian Cancer Hospital
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT04270461 2020-10-22
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Jiujiang University Affiliated Hospital
Phase 1 Withdrawn
NCT03414450 2018-10-25
Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Phase 1 Withdrawn
NCT01235468 2015-12-03
Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB)
Sheba Medical Center
Phase 1 Withdrawn